Skip to main content

Table 4 Baseline characteristics in patients with and without upper gastrointestinal bleeding

From: Comparison of risk scoring systems for upper gastrointestinal bleeding in patients after renal transplantation: a retrospective observational study in Hunan, China

Characteristics

Ā 

GIB (nā€‰=ā€‰55)

No GIB (nā€‰=ā€‰165)

p-value

Sex, n (%)

Male

41 (74.5%)

104 (63.0%)

0.12

Age, averageā€‰Ā±ā€‰SD

Ā 

47.31ā€‰Ā±ā€‰10.45

43.83ā€‰Ā±ā€‰10.62

0.04

BMI, kg/m2

Ā 

22.40ā€‰Ā±ā€‰3.68

21.61ā€‰Ā±ā€‰3.16

0.13

Systolic blood

Pressure, mmHg

Ā 

128ā€‰Ā±ā€‰24

127ā€‰Ā±ā€‰13

0.72

Heart rate (/min)

Ā 

92ā€‰Ā±ā€‰19

87ā€‰Ā±ā€‰15

0.16

Anticoagulant drugs usage, n (%)

Negative

49 (89.1%)

158 (95.8%)

0.07

Intravenous hormone usage,n (%)

Negative

36 (65.5%)

147 (89.1%)

ā€‰<ā€‰0.001

Hemoglobin, g/L

Ā 

111.46ā€‰Ā±ā€‰29.85

120.69ā€‰Ā±ā€‰24.73

0.03

Platelet, 109/L

Ā 

179.98ā€‰Ā±ā€‰84.18

201.60ā€‰Ā±ā€‰59.28

0.04

INR

Ā 

1.06ā€‰Ā±ā€‰0.25

0.98ā€‰Ā±ā€‰0.13

ā€‰<ā€‰0.001

Urea nitrogen, mmol/L

Ā 

13.04ā€‰Ā±ā€‰8.42

9.91ā€‰Ā±ā€‰6.14

ā€‰<ā€‰0.001

Creatinine,Ī¼mol/L

Ā 

170.89ā€‰Ā±ā€‰80.33

142.01ā€‰Ā±ā€‰87.85

ā€‰<ā€‰0.001

eGFR, ml / (min * 1.73m2)

Ā 

48.35ā€‰Ā±ā€‰26.95

58.31ā€‰Ā±ā€‰28.13

ā€‰<ā€‰0.001

Albumin, g/L

Ā 

34.48ā€‰Ā±ā€‰5.25

40.00ā€‰Ā±ā€‰5.52

ā€‰<ā€‰0.001

Calcineurin inhibitors, n (%)

Tacrolimus

47 (85.5%)

153 (92.7%)

0.10

Ā 

Cyclosporine A

8 (14.5%)

12 (7.3%)

Ā 

Complication

Diabetes, n (%)

No

47 (85.5%)

155 (93.9%)

0.05

Viral hepatitis (HBV/HCV), n (%)

Negative

43 (78.2%)

160 (97.0%)

ā€‰<ā€‰0.001

Pulmonary infection, n (%)

Negative

34 (61.8%)

116 (70.3%)

0.24

Cardio-cerebrovascular disease, n (%)

Negative

48 (87.3%)

161 (97.6%)

ā€‰<ā€‰0.001

Malignant tumor, n (%)

Negative

52 (94.5%)

160 (97.0%)

0.41

Outcome, n (%)

Mortality

16 (29.1%)

9 (5.5%)

0.03

  1. INR: International normalized ratio; eGFR: estimated glomerular filtration rate; BMI: Body mass index. HBV: hepatitis B virus; HCV: hepatitis C virus